stearic acid has been researched along with Breast Neoplasms in 15 studies
octadecanoic acid : A C18 straight-chain saturated fatty acid component of many animal and vegetable lipids. As well as in the diet, it is used in hardening soaps, softening plastics and in making cosmetics, candles and plastics.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, its molecular structure is susceptible to modifications due to cellular enzymes affecting its stability, bioavailability and hence, overall efficiency." | 5.51 | Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment. ( Bhargava, S; Gudem, S; Kulhari, H; Pooja, D; Radhakrishnan, R; Ramakrishna, S; Ravuri, HG, 2019) |
| "Chemical synthesis and characterization of a lipophilic ester conjugate, propofol stearate and evaluation of its anticancer efficacy on human breast cancer cell lines MDA-MB-361, MCF-7 and MDA-MB-231." | 3.79 | Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate. ( Abdelhameed, AS; Alanazi, AM; Chauhan, A; Jabeen, M; Khan, AA, 2013) |
| "We used MCF-7 and MDA-MB231 breast cancer cells incubated with SST for 24h, in the absence and presence of Vit C, at their EC50 concentrations, to evaluate membrane fatty acid-profiles together with the follow-up of EGFR and MAPK signaling pathways." | 1.51 | Effects of Somatostatin and Vitamin C on the Fatty Acid Profile of Breast Cancer Cell Membranes. ( Chatgilialoglu, C; Di Bella, G; Ferreri, C; Hanikoglu, A; Hanikoglu, F; Kucuksayan, E; Menounou, G; Ozben, T; Sansone, A, 2019) |
| " However, its molecular structure is susceptible to modifications due to cellular enzymes affecting its stability, bioavailability and hence, overall efficiency." | 1.51 | Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment. ( Bhargava, S; Gudem, S; Kulhari, H; Pooja, D; Radhakrishnan, R; Ramakrishna, S; Ravuri, HG, 2019) |
| "Therapeutic goals for metastatic breast cancer, including shrinkage of established metastasis and suppression of movement of tumor cells, are often hard to achieve and remain the main obstacles restricting the antimetastatic efficacy of targeted drug delivery systems (TDDSs)." | 1.51 | Highly Integrated Nanoplatform Based on an E-Selectin-Targeting Strategy for Metastatic Breast Cancer Treatment. ( Chen, J; Du, YZ; Liu, D; Lu, Y; Qi, J; Shu, GF; Wang, F; Xu, XL; Ying, XY; Zhu, ML, 2019) |
| "A significant percentage of breast cancer victims will suffer from metastases indicating that new approaches to preventing breast cancer metastasis are thus needed." | 1.40 | Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis. ( Hardy, RW; Rezonzew, G; Siegal, GP; Wang, D; Zhao, X, 2014) |
| "Fourteen breast cancer patients with a mean age of 61 years were recruited." | 1.39 | Carcinogenesis alters fatty acid profile in breast tissue. ( Azordegan, N; Fischer, G; Fraser, V; Hillyer, LM; Le, K; Ma, DW; Moghadasian, MH, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Balunas, MJ | 1 |
| Su, B | 1 |
| Landini, S | 1 |
| Brueggemeier, RW | 1 |
| Kinghorn, AD | 1 |
| Hanikoglu, A | 1 |
| Kucuksayan, E | 1 |
| Hanikoglu, F | 1 |
| Ozben, T | 1 |
| Menounou, G | 1 |
| Sansone, A | 1 |
| Chatgilialoglu, C | 1 |
| Di Bella, G | 1 |
| Ferreri, C | 1 |
| Lerata, MS | 1 |
| D'Souza, S | 1 |
| Sibuyi, NRS | 1 |
| Dube, A | 1 |
| Meyer, M | 1 |
| Samaai, T | 1 |
| Antunes, EM | 1 |
| Beukes, DR | 1 |
| Zhao, X | 2 |
| Shen, R | 1 |
| Bao, L | 1 |
| Wang, C | 1 |
| Yuan, H | 2 |
| Naik, H | 1 |
| Gauthier, T | 1 |
| Singh, S | 1 |
| Jois, S | 1 |
| Radhakrishnan, R | 1 |
| Pooja, D | 1 |
| Kulhari, H | 1 |
| Gudem, S | 1 |
| Ravuri, HG | 1 |
| Bhargava, S | 1 |
| Ramakrishna, S | 1 |
| Zheng, G | 1 |
| Zheng, M | 1 |
| Yang, B | 1 |
| Fu, H | 1 |
| Li, Y | 1 |
| Xu, XL | 1 |
| Zhu, ML | 1 |
| Liu, D | 1 |
| Shu, GF | 1 |
| Qi, J | 1 |
| Lu, Y | 1 |
| Wang, F | 1 |
| Ying, XY | 1 |
| Chen, J | 1 |
| Du, YZ | 1 |
| Khan, AA | 1 |
| Alanazi, AM | 1 |
| Jabeen, M | 1 |
| Chauhan, A | 1 |
| Abdelhameed, AS | 1 |
| Rezonzew, G | 1 |
| Wang, D | 1 |
| Siegal, GP | 1 |
| Hardy, RW | 1 |
| Hu, Y | 1 |
| Liu, N | 1 |
| Cheng, B | 1 |
| Tan, Y | 1 |
| Wen, L | 1 |
| Hu, F | 1 |
| Azordegan, N | 1 |
| Fraser, V | 1 |
| Le, K | 1 |
| Hillyer, LM | 1 |
| Ma, DW | 1 |
| Fischer, G | 1 |
| Moghadasian, MH | 1 |
| Baek, JS | 1 |
| Cho, CW | 1 |
| Chajès, V | 1 |
| Hultén, K | 1 |
| Van Kappel, AL | 1 |
| Winkvist, A | 1 |
| Kaaks, R | 1 |
| Hallmans, G | 1 |
| Lenner, P | 1 |
| Riboli, E | 1 |
| Zaridze, DG | 1 |
| Shevchenko, VE | 1 |
| Levchuk, AA | 1 |
| Lifanova, EE | 1 |
15 other studies available for stearic acid and Breast Neoplasms
| Article | Year |
|---|---|
Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay.
Topics: Aromatase; Biological Products; Breast Neoplasms; Fatty Acids; Female; Humans; Microsomes; Placenta; | 2006 |
Effects of Somatostatin and Vitamin C on the Fatty Acid Profile of Breast Cancer Cell Membranes.
Topics: Arachidonic Acids; Ascorbic Acid; Breast Neoplasms; Cell Extracts; Cell Line, Tumor; Cell Membrane; | 2019 |
Encapsulation of Variabilin in Stearic Acid Solid Lipid Nanoparticles Enhances Its Anticancer Activity in Vitro.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Survival; Female; Humans; Lipids; | 2020 |
Chitosan derived glycolipid nanoparticles for magnetic resonance imaging guided photodynamic therapy of cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chitosan; Chlorophyllides; Disease Model | 2020 |
Design of novel lipidated peptidomimetic conjugates for targeting EGFR heterodimerization in HER2 + cancer.
Topics: Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dimerization; Drug Design; Er | 2018 |
Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.
Topics: Animals; Antineoplastic Agents; Biological Transport; Bombesin; Breast Neoplasms; Catechin; Cell Lin | 2019 |
Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
Topics: Animals; Breast Neoplasms; Cell Death; Doxorubicin; Drug Liberation; Endocytosis; Female; Humans; Hy | 2019 |
Highly Integrated Nanoplatform Based on an E-Selectin-Targeting Strategy for Metastatic Breast Cancer Treatment.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Dextrans; Disease Models, Animal; Doxoru | 2019 |
Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; | 2013 |
Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Diet; Feeding Behavio | 2014 |
Sequential delivery of therapeutic agents using a rationally designed disulfide-linked glycolipid-like nanocarrier.
Topics: Adsorption; Antineoplastic Agents; Breast Neoplasms; Cell Cycle Checkpoints; Cell Survival; Chitosan | 2016 |
Carcinogenesis alters fatty acid profile in breast tissue.
Topics: Arachidonic Acid; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Transformation, Neoplast | 2013 |
2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transport | 2013 |
Fatty-acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden.
Topics: Breast Neoplasms; Case-Control Studies; Fatty Acids, Unsaturated; Female; Humans; Incidence; Middle | 1999 |
[Fatty acid composition of phospholipids of erythrocyte membranes and risk of breast cancer].
Topics: Adult; Arachidonic Acid; Arachidonic Acids; Breast Neoplasms; Erythrocyte Membrane; Fatty Acids; Fem | 1990 |